vs

Side-by-side financial comparison of Kiniksa Pharmaceuticals International, plc (KNSA) and MONARCH CASINO & RESORT INC (MCRI). Click either name above to swap in a different company.

Kiniksa Pharmaceuticals International, plc is the larger business by last-quarter revenue ($202.1M vs $136.6M, roughly 1.5× MONARCH CASINO & RESORT INC). MONARCH CASINO & RESORT INC runs the higher net margin — 20.2% vs 7.0%, a 13.2% gap on every dollar of revenue. On growth, Kiniksa Pharmaceuticals International, plc posted the faster year-over-year revenue change (65.0% vs 8.9%). Over the past eight quarters, Kiniksa Pharmaceuticals International, plc's revenue compounded faster (59.1% CAGR vs 3.2%).

Kiniksa Pharmaceuticals International plc is a global biopharmaceutical firm focused on discovering, developing and commercializing targeted therapies for patients with unmet medical needs, primarily in autoimmune, inflammatory and rare disease segments. It operates across major markets including North America, Europe and Asia, advancing a pipeline of clinical-stage and approved treatment candidates.

The Atlantis Casino Resort Spa is a hotel and casino located in Reno, Nevada, United States. It is owned and operated by Monarch Casino & Resort, Inc. Its three hotel towers have a combined 824 guest rooms and suites. The casino floor spans 64,814 sq ft. Often known simply as "Atlantis," it is one of Reno's most profitable and luxurious properties, competing directly with Peppermill Hotel Casino and Grand Sierra Resort for customers. Nearly $150 million has been spent on upgrading the facility.

KNSA vs MCRI — Head-to-Head

Bigger by revenue
KNSA
KNSA
1.5× larger
KNSA
$202.1M
$136.6M
MCRI
Growing faster (revenue YoY)
KNSA
KNSA
+56.1% gap
KNSA
65.0%
8.9%
MCRI
Higher net margin
MCRI
MCRI
13.2% more per $
MCRI
20.2%
7.0%
KNSA
Faster 2-yr revenue CAGR
KNSA
KNSA
Annualised
KNSA
59.1%
3.2%
MCRI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
KNSA
KNSA
MCRI
MCRI
Revenue
$202.1M
$136.6M
Net Profit
$14.2M
$27.6M
Gross Margin
89.6%
Operating Margin
9.8%
25.6%
Net Margin
7.0%
20.2%
Revenue YoY
65.0%
8.9%
Net Profit YoY
259.8%
38.9%
EPS (diluted)
$0.18
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KNSA
KNSA
MCRI
MCRI
Q1 26
$136.6M
Q4 25
$202.1M
$140.0M
Q3 25
$180.9M
$142.8M
Q2 25
$156.8M
$136.9M
Q1 25
$137.8M
$125.4M
Q4 24
$122.5M
$134.5M
Q3 24
$112.2M
$137.9M
Q2 24
$108.6M
$128.1M
Net Profit
KNSA
KNSA
MCRI
MCRI
Q1 26
$27.6M
Q4 25
$14.2M
$22.9M
Q3 25
$18.4M
$31.6M
Q2 25
$17.8M
$27.0M
Q1 25
$8.5M
$19.9M
Q4 24
$-8.9M
$4.2M
Q3 24
$-12.7M
$27.6M
Q2 24
$-3.9M
$22.7M
Gross Margin
KNSA
KNSA
MCRI
MCRI
Q1 26
Q4 25
89.6%
20.8%
Q3 25
88.8%
26.7%
Q2 25
88.1%
25.5%
Q1 25
87.0%
20.2%
Q4 24
85.4%
2.9%
Q3 24
82.1%
25.6%
Q2 24
88.7%
23.0%
Operating Margin
KNSA
KNSA
MCRI
MCRI
Q1 26
25.6%
Q4 25
9.8%
21.3%
Q3 25
13.3%
27.1%
Q2 25
12.9%
25.8%
Q1 25
9.6%
20.4%
Q4 24
-15.7%
3.1%
Q3 24
-8.6%
25.5%
Q2 24
-0.1%
22.9%
Net Margin
KNSA
KNSA
MCRI
MCRI
Q1 26
20.2%
Q4 25
7.0%
16.4%
Q3 25
10.2%
22.1%
Q2 25
11.4%
19.7%
Q1 25
6.2%
15.8%
Q4 24
-7.3%
3.1%
Q3 24
-11.3%
20.0%
Q2 24
-3.6%
17.7%
EPS (diluted)
KNSA
KNSA
MCRI
MCRI
Q1 26
$1.52
Q4 25
$0.18
$1.25
Q3 25
$0.23
$1.69
Q2 25
$0.23
$1.44
Q1 25
$0.11
$1.05
Q4 24
$-0.11
$0.25
Q3 24
$-0.18
$1.47
Q2 24
$-0.06
$1.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KNSA
KNSA
MCRI
MCRI
Cash + ST InvestmentsLiquidity on hand
$414.1M
$120.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$567.6M
$549.8M
Total Assets
$763.6M
$725.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KNSA
KNSA
MCRI
MCRI
Q1 26
$120.1M
Q4 25
$414.1M
Q3 25
$352.1M
Q2 25
$307.8M
Q1 25
$268.3M
Q4 24
$243.6M
Q3 24
$223.8M
Q2 24
$218.8M
Stockholders' Equity
KNSA
KNSA
MCRI
MCRI
Q1 26
$549.8M
Q4 25
$567.6M
$537.7M
Q3 25
$535.4M
$558.4M
Q2 25
$495.0M
$539.2M
Q1 25
$457.5M
$535.6M
Q4 24
$438.4M
$517.7M
Q3 24
$437.0M
$513.3M
Q2 24
$435.1M
$498.4M
Total Assets
KNSA
KNSA
MCRI
MCRI
Q1 26
$725.2M
Q4 25
$763.6M
$712.8M
Q3 25
$712.3M
$725.4M
Q2 25
$661.1M
$705.8M
Q1 25
$599.3M
$712.1M
Q4 24
$580.6M
$691.6M
Q3 24
$555.3M
$671.1M
Q2 24
$542.4M
$672.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KNSA
KNSA
MCRI
MCRI
Operating Cash FlowLast quarter
$53.9M
Free Cash FlowOCF − Capex
$53.3M
FCF MarginFCF / Revenue
26.4%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
3.80×
TTM Free Cash FlowTrailing 4 quarters
$136.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KNSA
KNSA
MCRI
MCRI
Q1 26
Q4 25
$53.9M
$38.1M
Q3 25
$33.7M
$56.0M
Q2 25
$28.1M
$34.1M
Q1 25
$22.3M
$36.5M
Q4 24
$18.8M
$37.8M
Q3 24
$-2.2M
$40.3M
Q2 24
$5.2M
$24.3M
Free Cash Flow
KNSA
KNSA
MCRI
MCRI
Q1 26
Q4 25
$53.3M
$32.2M
Q3 25
$33.0M
$53.5M
Q2 25
$27.9M
$26.0M
Q1 25
$22.2M
$16.6M
Q4 24
$18.6M
$26.2M
Q3 24
$35.4M
Q2 24
$11.0M
FCF Margin
KNSA
KNSA
MCRI
MCRI
Q1 26
Q4 25
26.4%
23.0%
Q3 25
18.2%
37.5%
Q2 25
17.8%
19.0%
Q1 25
16.1%
13.3%
Q4 24
15.2%
19.5%
Q3 24
25.7%
Q2 24
8.5%
Capex Intensity
KNSA
KNSA
MCRI
MCRI
Q1 26
Q4 25
0.3%
4.2%
Q3 25
0.4%
1.7%
Q2 25
0.1%
5.9%
Q1 25
0.1%
15.8%
Q4 24
0.2%
8.6%
Q3 24
0.0%
3.6%
Q2 24
0.0%
10.4%
Cash Conversion
KNSA
KNSA
MCRI
MCRI
Q1 26
Q4 25
3.80×
1.66×
Q3 25
1.83×
1.77×
Q2 25
1.58×
1.26×
Q1 25
2.61×
1.84×
Q4 24
8.98×
Q3 24
1.46×
Q2 24
1.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KNSA
KNSA

Segment breakdown not available.

MCRI
MCRI

Casino$79.7M58%
Food and beverage$31.7M23%
Hotel$19.0M14%
Other$6.1M5%

Related Comparisons